CervoMed Inc. News

Latest updates and market news for CRVO

7 news

Nov 30 - Dec 6, 2025

Page 1

Argus Research

a day ago

Daily – Vickers Top Insider Picks for 12/05/2025

📊

AI Sentiment

Positive

6/10

CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies

GlobeNewswire

2 days ago

CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies

Argus Research

2 days ago

Daily – Vickers Top Insider Picks for 12/04/2025

📊

AI Sentiment

Positive

6/10

Argus Research

3 days ago

Daily – Vickers Top Insider Picks for 12/03/2025

➖

AI Sentiment

Neutral

5/10

CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)

GlobeNewswire

4 days ago

CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)

📈

AI Sentiment

Highly Positive

8/10

Argus Research

4 days ago

Daily – Vickers Top Insider Picks for 12/02/2025

➖

AI Sentiment

Neutral

5/10

Argus Research

5 days ago

Daily – Vickers Top Insider Picks for 12/01/2025

➖

AI Sentiment

Neutral

5/10

Share this news page

Share on Social Networks: